MRC Logo

bbsrc logo

NIBSC Logo

HPA Logo


 

Mission Statement

The UK Stem Cell Bank works with and for the scientific and clinical community to assure the quality of human stem cell lines used in research and therapy. More....

Cell Lines currently available

The lines currently available are:  Shef-1, Shef-2, Shef-3, Shef-4, Shef-6, Shef-7, hES-NCL-1, KCL-001, Nott 1, Nott 2, NCL-2, NCL-3, NCL-4, NCL-5 and MEL-1.

Applications to access the lines from the Bank should be made to the UK Steering Committee.  Application forms are available via the MRC website.

Announcement on stem cell lines in the
NIH registry

The Steering Committee is satisfied that the majority of stem cell lines in the USA National Institutes for Health (NIH) registry are ethically sourced, and therefore can be imported into the UK. However, it has recently come to the Committee's attention that the consent procedures for lines BG01, BG02 and BG03 may not meet the high standards required for acceptance into the Bank and for use in the UK.

Stem cell catalogue now available online

Cell lines currently available from the UKSCB are now listed in the Stem Cell Catalogue.

The catalogue also lists the lines due for release in the near future plus those accessioned and accepted by the Steering Committee. The catalogue can be accessed by clicking the link on the left.

Regulatory Route Map for Stem Cell Lines

An Interim UK Regulatory Route Map for Stem Cell Research & Manufacture has been developed by key stakeholders. It is intended to be a reference tool for those who wish to develop a programme of stem cell research and manufacture, ultimately leading to clinical application. The map has been developed by the Department of Health with the support of the Gene Therapy Advisory Committee, Health & Safety Executive, Home Office, Human Fertilisation & Embryology Authority, Human Tissue Authority, Medicines & Healthcare products Regulatory Agency, Medical Research Council, NHS Blood & Transplant Authority, Scottish National Blood Transfusion Service, Advisory Committee on the Safety of Blood, Tissues & Organs, & the UK Stem Cell Bank. The map